Roadmap On Improvements To EMA's Literature Monitoring Service Due By Year End
The European Medicines Agency will be looking for quick wins as well as long-term improvements when it revises its medical literature monitoring service. It will soon publish a roadmap for improving the service with details of when the changes might occur.
You may also be interested in...
A roadmap to improve the European Medicines Agency’s medical literature monitoring service will be published soon. While some of industry’s suggestions to expand or improve the service have been rejected, many others have either already been implemented or will materialize in the near future.
From looking at ways to reduce the number of audits undertaken by companies to fulfil their pharmacovigilance obligations to calling for harmonized assessment of risk management plans, the EU generics and biosimilars industry group Medicines for Europe says it is ready to explore some radical proposals to simplify the current pharmacovigilance requirements.
The European Medicines Agency is looking at ways to improve and simplify its medical literature monitoring service, which has created new complexities for the generics pharmaceutical industry.